NCI, FDA Courting Drug Sponsors To Add Clinical Trials To PDQ Database
In Brief: ACCC Honors Henry Lynch; Gunderson Names Chair, Mayo Oncology Department
PDQ Needs Change, Advocates Say, NBCC to Build Its Own Trials Registry
Richard Bloch’s Dream Of Empowering Patients Had Rough Beginning
Professional Societies: Three Groups To File brief In Fisher’s Appeal
NCI News: Communications Office Seeks Partners for Education Programs
Letter to the Editors: Researchers Must Keep Up NIH Advocacy Particularly Now
Trending Stories
- Preparing to take care of each other in ways we never imagined
- 20 years of EGFR research: Ramalingam, Carbone, Politi, Jänne, Govindan reflect
- From the chairs of ECOG-ACRIN: A perspective on indirect costs
- On a new podcast, VCU’s Winn and City of Hope’s Carpten discuss the mission—and the future—of cancer centers
The Cancer Letter’s new podcast offers insight into cancer policy in a landscape of uncertainty - FDA grants Cytotron Breakthrough Device Designation for breast, liver and pancreatic cancers
- What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns”